Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 106684
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.106684
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.106684
Figure 6 Survival analysis.
Survival analysis was performed on all patients who received immunotherapy in combination with compound Kushen injection. A: Overall survival curve of patients in the ascites (AS) and no-AS groups; B: Progression-free survival curve of patients in AS and no-AS groups; C: Overall survival curve of patients grouped by systemic immune-inflammation index-prognostic nutritional index; D: Progression-free survival curve of patients grouped by SII-PNI. AS: Ascites; SII: Systemic immune-inflammation index; PNI: Prognostic nutritional index; PFS: Progression-free survival.
- Citation: Zhu YF, Zhang DW, Zhang M, Yu MH, Zhang SH, Wu YY. Prognostic value of immune-inflammation and nutritional indices in advanced hepatocellular carcinoma patients receiving immunotherapy with compound Kushen injection. World J Gastrointest Oncol 2025; 17(7): 106684
- URL: https://www.wjgnet.com/1948-5204/full/v17/i7/106684.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i7.106684